PHOENIX — Although challenges remain, remote digital health practices can be implemented for most aspects of asthma evaluation and management, according to a speaker at the American Academy of Allergy, Asthma & Immunology Annual Meeting. Presenting the 24th year of the Elliot F. Ellis Memorial Lectureship during the meeting’s presidential plenary session, Andrew Liu, MD, FAAAAI, director […]
Respiri has teamed up with mTelehealth to provide customers with the Wheezo device for evaluation, testing and pilot programs, which are considered the first steps towards seeking reimbursement for the device mTelehealth placed a second order for additional Wheezo devices, representing revenues of around US$24,000 (around A$33,600) on top of the US$150,000 (A$210,000) order received […]
• mTelehealth to provide paying customers with devices for evaluation, testing and pilot programs, the first steps in seeking to secure reimbursement for wheezo®. • Targeted senior medical decision makers from over 600 of mTelehealth target customers will be provided with wheezo® devices to allow for internal review, testing and pilot programs. • The institutions […]
Paediatric Respiratory Reviews Available online 17 January 2022In Press, Journal Pre-proofWhat are Journal Pre-proof articles? ReviewA scoping review of mHealth monitoring of pediatric bronchial asthma before and during COVID-19 pandemic Author links open overlay panelNurlanDauletbaevabcdS.Zoe OftringeWidedAkikfLukasMichaelis-BraunaJuliaKorelaLarry C.LandsbcSusanneWaldmanngBeate S.MüllerhMichaelDreheriGernotRohdejClaus F.VogelmeieraSebastianKuhneaDepartment of Internal, Respiratory and Critical Care Medicine, Philipps University of Marburg, Marburg, Germany (Member of the […]
The e-health company’s shares closed in the green today on news of a new partnership Published December 23, 4:39pm AEDT The Respiri Ltd (ASX: RSH) share price leapt 14% to 6.5 cents in early trading this morning. This came following the announcement of a distribution and marketing deal with a United States healthcare company. At the closing bell, Respiri shares had […]
Markets Reporter jessica.defreitas@themarketherald.com.au 23 December 2021 14:54 (AEDT) Respiri (RSH) signs a five-year non-exclusive distribution and marketing deal with US-based remote patient monitoring (RPM) and chronic care provider, mTelehealth mTelehealth will initially order US$150,000 (A$208,087) worth of wheezo devices and services but the deal is expected to generate US$1 million (A$1.4 million) in sales Respiri believes […]
Respiri (RSH) has received United States Food and Drug Administration (FDA) clearance for its wheezing aid, Wheezo Wheezo monitors wheezing to manage and improve asthma With the green tick from the FDA, the company can now market and sell the technology in the United States On the market this afternoon, Respiri is in the grey […]